-
R658603-5mg(Rac)-OSMI-1 is the racemate of OSMI-1. OSMI-1 is a cell-permeable O-GlcNAc transferase (OGT) inhibitor with an IC 50 value of 2.7 μM. OSMI-1 inhibits protein O-linked N-acetylglucosamine (O-GlcNAcylation) in several mammalian cell lines without
-
P646667-100mg(Rac)-PF-06256142 is the less effective enantiomer of PF-06256142 ( HY-119943 ). (Rac)-PF-06256142 is an agonist of D1 receptor , with an EC 50 of 107 nM. (Rac)-PF-06256142 can be used for the research of schizophrenia and Parkinson's
-
P646667-10mg(Rac)-PF-06256142 is the less effective enantiomer of PF-06256142 ( HY-119943 ). (Rac)-PF-06256142 is an agonist of D1 receptor , with an EC 50 of 107 nM. (Rac)-PF-06256142 can be used for the research of schizophrenia and Parkinson's
-
P646667-25mg(Rac)-PF-06256142 is the less effective enantiomer of PF-06256142 ( HY-119943 ). (Rac)-PF-06256142 is an agonist of D1 receptor , with an EC 50 of 107 nM. (Rac)-PF-06256142 can be used for the research of schizophrenia and Parkinson's
-
P646667-50mg(Rac)-PF-06256142 is the less effective enantiomer of PF-06256142 ( HY-119943 ). (Rac)-PF-06256142 is an agonist of D1 receptor , with an EC 50 of 107 nM. (Rac)-PF-06256142 can be used for the research of schizophrenia and Parkinson's
-
P646667-5mg(Rac)-PF-06256142 is the less effective enantiomer of PF-06256142 ( HY-119943 ). (Rac)-PF-06256142 is an agonist of D1 receptor , with an EC 50 of 107 nM. (Rac)-PF-06256142 can be used for the research of schizophrenia and Parkinson's
-
P654688-1ml(Rac)-PF-06256142 is the less effective enantiomer of PF-06256142 ( HY-119943 ). (Rac)-PF-06256142 is an agonist of D1 receptor , with an EC 50 of 107 nM. (Rac)-PF-06256142 can be used for the research of schizophrenia and Parkinson's
-
P648266-100mg(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specific hypoxia-inducible factor 2a (HIF-2α) inhibitor with an IC 50 of 0.01 μMForm:SolidIC50&: Target:IC50: 0.01 μM (HIF-2α).
-
P648266-10mg(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specific hypoxia-inducible factor 2a (HIF-2α) inhibitor with an IC 50 of 0.01 μMForm:SolidIC50&: Target:IC50: 0.01 μM (HIF-2α).
-
P648266-50mg(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specific hypoxia-inducible factor 2a (HIF-2α) inhibitor with an IC 50 of 0.01 μMForm:SolidIC50&: Target:IC50: 0.01 μM (HIF-2α).
-
P648266-5mg(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specific hypoxia-inducible factor 2a (HIF-2α) inhibitor with an IC 50 of 0.01 μMForm:SolidIC50&: Target:IC50: 0.01 μM (HIF-2α).
-
P655359-1ml(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specific hypoxia-inducible factor 2a (HIF-2α) inhibitor with an IC 50 of 0.01 μMIC50&: Target:IC50: 0.01 μM (HIF-2α).